These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12924611)

  • 1. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.
    Keller C
    Ther Apher Dial; 2003 Jun; 7(3):345-9. PubMed ID: 12924611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced extracorporeal low-density lipoprotein precipitation.
    Mellwig KP
    Ther Apher Dial; 2003 Jun; 7(3):365-9. PubMed ID: 12924614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporal low-density lipoprotein elimination by immunoadsorption.
    Ritter MM; Parhofer KG
    Ther Apher Dial; 2003 Jun; 7(3):370-2. PubMed ID: 12924615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
    Klingel R; Fassbender T; Fassbender C; Göhlen B
    Ther Apher Dial; 2003 Jun; 7(3):350-8. PubMed ID: 12924612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.
    Gordon BR; Kelsey SF; Bilheimer DW; Brown DC; Dau PC; Gotto AM; Illingworth DR; Jones PH; Leitman SF; Prihoda JS
    Am J Cardiol; 1992 Oct; 70(11):1010-6. PubMed ID: 1414897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.
    Higashikata T; Mabuchi H
    Ther Apher Dial; 2003 Aug; 7(4):402-7. PubMed ID: 12887722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apheresis technology for prevention and regression of atherosclerosis: an overview.
    Yamamoto A; Kawaguchi A; Harada-Shiba M; Tsushima M; Kojima S
    Ther Apher; 1997 Aug; 1(3):233-41. PubMed ID: 10225745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein apheresis: an overview.
    Bambauer R; Schiel R; Latza R
    Ther Apher Dial; 2003 Aug; 7(4):382-90. PubMed ID: 12887719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of different low-density lipoprotein apheresis methods.
    Parhofer KG; Geiss HC; Schwandt P
    Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LDL-apheresis--clinical indication and utility].
    Nakamura T; Ishikawa K
    Nihon Rinsho; 1999 Dec; 57(12):2854-61. PubMed ID: 10638225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
    Koga N
    Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia.
    Thompson GR; Kitano Y
    Ther Apher; 1997 Feb; 1(1):13-6. PubMed ID: 10225774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits.
    Yamamoto T; Yamashita T
    Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE; Vessby B; Wikström B; Danielson BG
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.